ATE374603T1 - Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation - Google Patents

Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation

Info

Publication number
ATE374603T1
ATE374603T1 AT01995691T AT01995691T ATE374603T1 AT E374603 T1 ATE374603 T1 AT E374603T1 AT 01995691 T AT01995691 T AT 01995691T AT 01995691 T AT01995691 T AT 01995691T AT E374603 T1 ATE374603 T1 AT E374603T1
Authority
AT
Austria
Prior art keywords
peptide
lipid nanoparticles
amphiphilic lipid
protein incorporation
incorporation
Prior art date
Application number
AT01995691T
Other languages
English (en)
Inventor
Curto Maria Dorly Del
Daniela Chicco
Pierandrea Esposito
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of ATE374603T1 publication Critical patent/ATE374603T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01995691T 2000-12-27 2001-12-17 Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation ATE374603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128555 2000-12-27
EP01125742 2001-10-26

Publications (1)

Publication Number Publication Date
ATE374603T1 true ATE374603T1 (de) 2007-10-15

Family

ID=26071689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01995691T ATE374603T1 (de) 2000-12-27 2001-12-17 Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation

Country Status (15)

Country Link
US (1) US20040081688A1 (de)
EP (1) EP1345597B1 (de)
JP (1) JP4072057B2 (de)
AR (1) AR032073A1 (de)
AT (1) ATE374603T1 (de)
AU (1) AU2002226374B2 (de)
CA (1) CA2431888C (de)
CY (1) CY1106995T1 (de)
DE (1) DE60130791T2 (de)
DK (1) DK1345597T3 (de)
ES (1) ES2291379T3 (de)
IL (2) IL156531A0 (de)
PT (1) PT1345597E (de)
SI (1) SI1345597T1 (de)
WO (1) WO2002051390A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
WO2005027872A2 (en) * 2003-06-04 2005-03-31 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050170004A1 (en) * 2003-10-31 2005-08-04 Vered Rosenberger Nanoparticles for drug delivery
JP3903061B2 (ja) * 2003-12-24 2007-04-11 株式会社Ｌｔｔバイオファーマ 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
CN103315954A (zh) * 2005-07-18 2013-09-25 麻萨诸塞州洛厄尔大学 制备与使用纳米乳剂的组合物和方法
EP1951200A2 (de) * 2005-08-09 2008-08-06 Nanobio Corporation Eine nanoemulsion enthaltende zusammensetzungen mit entzündungshemmender wirkung
EP1924248B1 (de) * 2005-09-15 2014-10-22 Council of Scientific and Industrial Research Ph-empfindliche nanoteilchenförmige formulierung zur oralen abgabe von proteinen/peptiden
KR102110379B1 (ko) 2005-12-01 2020-05-14 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US8361494B2 (en) * 2006-03-10 2013-01-29 The Trustees Of The University Of Pennsylvania Biomimetic iron-oxide-containing lipoprotein and related materials
US20100172943A1 (en) * 2006-12-01 2010-07-08 Anterios, Inc. Peptide nanoparticles and uses therefor
JP2010528981A (ja) 2006-12-01 2010-08-26 アンテリオス， インコーポレイテッド 両親媒性実体ナノ粒子
KR100834687B1 (ko) * 2007-02-21 2008-06-02 주식회사 엘지생활건강 히노키티올 함유 지질 나노 입자 및 그의 제조방법
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
CN101322719B (zh) * 2007-06-15 2012-03-07 杭州民生药业有限公司 一种三氧化二砷固体脂质纳米粒及其制剂
JP2012501966A (ja) 2008-06-16 2012-01-26 バインド バイオサイエンシズ インコーポレイテッド ビンカアルカロイド含有治療用ポリマーナノ粒子並びにその製造方法及び使用方法
EA021422B1 (ru) * 2008-06-16 2015-06-30 Бинд Терапьютикс, Инк. Полимерные наночастицы, содержащие терапевтическое средство, и способ их получения
US8613951B2 (en) * 2008-06-16 2013-12-24 Bind Therapeutics, Inc. Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
KR101848095B1 (ko) * 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
US8563041B2 (en) 2008-12-12 2013-10-22 Bind Therapeutics, Inc. Therapeutic particles suitable for parenteral administration and methods of making and using same
EP2379064B1 (de) 2008-12-15 2020-02-26 Pfizer Inc. Lange zirkulierende nanoteilchen zur verzögerten freisetzung von therapeutischen mitteln
EP2266546A1 (de) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Verfahren zur Herstellung kolloidaler Systeme zur Abgabe von Wirkstoffen
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
EP2451950B9 (de) * 2009-07-06 2016-11-23 Variation Biotechnologies Inc. Verfahren zur vesikelherstellung und darin hergestellte formulierungen
TR201906255T4 (tr) 2009-12-11 2019-05-21 Pfizer Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar.
ES2780156T3 (es) 2009-12-15 2020-08-24 Pfizer Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
BR112013000394B8 (pt) 2010-07-06 2022-01-18 Variation Biotechnologies Inc Composição imunogênica, uso da mesma e método para preparar a referida composição
KR20130100290A (ko) 2010-08-30 2013-09-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
CN107296792B (zh) * 2011-01-13 2021-07-27 变异生物技术公司 囊泡及由其产生之制剂的制备方法
EP2663327A4 (de) 2011-01-13 2015-12-02 Variation Biotechnologies Inc Zusammensetzungen und verfahren zur behandlung von virusinfektionen
US20120189677A1 (en) * 2011-01-20 2012-07-26 Stephen Tonge Formulations
DE102011116069A1 (de) 2011-10-18 2013-04-18 Dr. Rimpler Gmbh Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
EP4008354A1 (de) 2012-01-27 2022-06-08 Variation Biotechnologies Inc. Verfahren und zusammensetzungen für therapeutika
PL2895156T3 (pl) 2012-09-17 2019-09-30 Pfizer Inc. Sposób wytwarzania nanocząstek terapeutycznych
WO2014092596A1 (ru) * 2012-12-12 2014-06-19 Vitkalova Tamara Aleksandrovna Субстанции и фармацевтические композиции на их основе для лечения заболеваний человека, в том числе, для лечения хронических вирусных гепатитов "в" и "с"
US9693958B2 (en) * 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
UA121967C2 (uk) 2014-03-14 2020-08-25 Пфайзер Інк. Терапевтичні наночастинки, які містять терапевтичний засіб, та способи їх отримання та застосування
US20170172937A1 (en) * 2014-03-24 2017-06-22 University Of Mississippi Systems and methods for preparing solid lipid nanoparticles
AU2017360346B2 (en) 2016-11-21 2023-11-23 Eirion Therapeutics, Inc. Transdermal delivery of large agents
IL267923B2 (en) * 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤
JP2020152673A (ja) 2019-03-20 2020-09-24 株式会社リコー ナノ粒子及びナノ粒子の製造方法、並びに医薬
CN111388451B (zh) * 2020-04-29 2023-05-23 南京工业大学 蛋白自组装铁基纳米粒及其制备方法与抗肿瘤药物递送系统中的应用
US20230355540A1 (en) 2020-09-29 2023-11-09 Oxford University Innovation Limited Stroke treatment
CN113952301A (zh) * 2021-11-17 2022-01-21 胡振华 中链脂肪酸作为促吸收剂制备药物组合物乳剂的应用
DE202023100649U1 (de) 2023-02-10 2023-03-22 Cineolux Gmbh Dispersion und Zubereitung zur topischen Anwendung
DE102023103292A1 (de) 2023-02-10 2024-08-14 Cineolux Gmbh Dispersion und Zubereitung zur topischen Anwendung
WO2024259158A2 (en) * 2023-06-13 2024-12-19 Cornell University Lipid nanoparticles for peptide delivery and methods of making and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
DE19819273A1 (de) * 1998-04-30 1999-11-11 Pharmatec International S Giul Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
US6967028B2 (en) * 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration

Also Published As

Publication number Publication date
WO2002051390A3 (en) 2002-10-10
CA2431888C (en) 2010-06-01
DK1345597T3 (da) 2007-12-10
EP1345597B1 (de) 2007-10-03
DE60130791T2 (de) 2008-07-17
EP1345597A2 (de) 2003-09-24
US20040081688A1 (en) 2004-04-29
WO2002051390A2 (en) 2002-07-04
CA2431888A1 (en) 2002-07-04
IL156531A (en) 2008-11-03
JP2004519447A (ja) 2004-07-02
CY1106995T1 (el) 2012-09-26
ES2291379T3 (es) 2008-03-01
AU2002226374B2 (en) 2006-06-08
SI1345597T1 (sl) 2007-12-31
JP4072057B2 (ja) 2008-04-02
PT1345597E (pt) 2007-10-29
AR032073A1 (es) 2003-10-22
DE60130791D1 (de) 2007-11-15
IL156531A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
ATE374603T1 (de) Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation
CY2022030I2 (el) Μειγματα αναλογων κυκλοσπορινης και η χρηση τους ως ανοσορρυθμιστικοι παραγοντες
EP1636250A4 (de) Selbstorganisierendes, modifikationen enthaltende peptide und verfahren zu deren anwendung
IS2620B (is) Mennskgerð mótefni sem greina beta-amýlóíðpeptíð
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
AR027815A1 (es) Formulacion farmaceutica y metodo para su produccion
NO20021333L (no) Sammensetning som innbefatter kasein- og myseprotein
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
DE60139305D1 (de) Zusammensetzung aus antigen und glykolipid zur sublingualen verabreichung
GB2369283B (en) Incorporation of soy proteins in cheese
NO20025158D0 (no) Lipidpreparat og anvendelse derav
EP1369101A4 (de) Kosmetisches w/ö/w-emulsionspräparat
EP1622585A4 (de) Lipid-platin-komplexe und anwendungsverfahren dafür
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DE60117622D1 (de) Produkte zur nagelpflege
DE60111459D1 (de) Zubereitungen zur transdermalen verabreichung hydrophiler substanzen
ATA6742001A (de) Verfahren und einrichtung zur bestimmung des weiblichen hormonstatus
EP1337543A4 (de) Streptavidin-bindende peptide und deren verwendung
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
FI20030315A0 (fi) Menetelmiä ja konstruktioita valikoitujen aminohappojen pitoisuuksien lisäämiseksi siemenissä
PL1693378T3 (pl) Białko NMB1125 i jego zastosowanie w kompozycjach farmaceutycznych
GB0000540D0 (en) Protein and/or peptide based artificial saliva
SI1610820T1 (sl) Visokokoncentrirane formulacije protitelesa in proteinov

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1345597

Country of ref document: EP